;PMID: 12203220
;source_file_616.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..32] = [t:0..32]
;1)sentence:[e:37..125] = [t:37..125]
;2)section:[e:129..221] = [t:129..221]
;3)section:[e:225..289] = [t:225..289]
;4)sentence:[e:293..377] = [t:293..377]
;5)sentence:[e:378..456] = [t:378..456]
;6)sentence:[e:457..666] = [t:457..666]
;7)sentence:[e:667..844] = [t:667..844]
;8)sentence:[e:845..1067] = [t:845..1067]
;9)sentence:[e:1068..1172] = [t:1068..1172]
;10)sentence:[e:1173..1293] = [t:1173..1293]
;11)sentence:[e:1294..1333] = [t:1294..1333]
;12)section:[e:1334..1354] = [t:1334..1354]
;13)section:[e:1358..1403] = [t:1358..1403]

;section 0 Span:0..32
;Hum Pathol  2002 Aug;33(8):852-5
(SEC
  (FRAG (NNP:[0..3] Hum) (NNP:[4..10] Pathol) (CD:[12..16] 2002)
        (CD:[17..22] Aug;3) (CD:[22..23] 3) (NN:[23..24] -LRB-) (NN:[24..25] 8)
        (NN:[25..26] -RRB-) (::[26..27] :) (CD:[27..29] 85) (::[29..32] 2-5)))

;sentence 1 Span:37..125
;Two case reports of childhood liver cell adenomas harboring beta-catenin 
;abnormalities.
;[57..86]:malignancy:"childhood liver cell adenomas"
;[97..109]:gene-rna:"beta-catenin"
(SENT
  (NP-HLN
    (NP (CD:[37..40] Two) (NN:[41..45] case) (NNS:[46..53] reports))
    (PP (IN:[54..56] of)
      (NP
        (NP (NN:[57..66] childhood)
          (NML (NN:[67..72] liver) (NN:[73..77] cell))
          (NNS:[78..86] adenomas))
        (VP (VBG:[87..96] harboring)
          (NP (NN:[97..109] beta-catenin) (NNS:[111..124] abnormalities)))))
    (.:[124..125] .)))

;section 2 Span:129..221
;Takayasu H, Motoi T, Kanamori Y, Kitano Y, Nakanishi H, Tange T, Nakagawara
;A,  Hashizume K.
(SEC
  (FRAG (NNP:[129..137] Takayasu) (NNP:[138..140] H,) (NNP:[141..146] Motoi)
        (NNP:[147..148] T) (,:[148..149] ,) (NNP:[150..158] Kanamori)
        (NNP:[159..160] Y) (,:[160..161] ,) (NNP:[162..168] Kitano)
        (NNP:[169..170] Y) (,:[170..171] ,) (NNP:[172..181] Nakanishi)
        (NNP:[182..184] H,) (NNP:[185..190] Tange) (NNP:[191..192] T)
        (,:[192..193] ,) (NNP:[194..204] Nakagawara) (NNP:[205..206] A)
        (,:[206..207] ,) (NNP:[209..218] Hashizume) (NNP:[219..221] K.)))

;section 3 Span:225..289
;Department of Pediatric Surgery, Tokyo University, Tokyo, Japan.
(SEC
  (FRAG (NNP:[225..235] Department) (IN:[236..238] of)
        (NNP:[239..248] Pediatric) (NNP:[249..256] Surgery) (,:[256..257] ,)
        (NNP:[258..263] Tokyo) (NNP:[264..274] University) (,:[274..275] ,)
        (NNP:[276..281] Tokyo) (,:[281..282] ,) (NNP:[283..288] Japan)
        (.:[288..289] .)))

;sentence 4 Span:293..377
;The benign epithelial neoplasm liver cell adenoma is rare, especially in 
;childhood.
;[297..342]:malignancy:"benign epithelial neoplasm liver cell adenoma"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[293..296] The) (JJ:[297..303] benign) (JJ:[304..314] epithelial)
          (NN:[315..323] neoplasm))
      (NP
        (NML (NN:[324..329] liver) (NN:[330..334] cell))
        (NN:[335..342] adenoma)))
    (VP (VBZ:[343..345] is)
      (ADJP-PRD (JJ:[346..350] rare))
      (,:[350..351] ,)
      (ADVP (RB:[352..362] especially)
        (PP (IN:[363..365] in)
          (NP (NN:[367..376] childhood)))))
    (.:[376..377] .)))

;sentence 5 Span:378..456
;We report 2 such cases, 1 of which was associated with Prader-Willi 
;syndrome.
(SENT
  (S
    (NP-SBJ (PRP:[378..380] We))
    (VP (VBP:[381..387] report)
      (NP
        (NP (CD:[388..389] 2) (JJ:[390..394] such) (NNS:[395..400] cases))
        (,:[400..401] ,)
        (SBAR
          (WHNP-1
            (NP (CD:[402..403] 1))
            (WHPP (IN:[404..406] of)
              (WHNP (WDT:[407..412] which))))
          (S
            (NP-SBJ-1 (-NONE-:[412..412] *T*))
            (VP (VBD:[413..416] was)
              (VP (VBN:[417..427] associated)
                (NP-1 (-NONE-:[427..427] *))
                (PP-CLR (IN:[428..432] with)
                  (NP
                    (NML (NNP:[433..439] Prader) (HYPH:[439..440] -)
                         (NNP:[440..445] Willi))
                    (NN:[447..455] syndrome)))))))))
    (.:[455..456] .)))

;sentence 6 Span:457..666
;Differential diagnosis of the liver cell adenomas on the basis of 
;histopathologic findings proved difficult and was based on the absence of 
;cellular and nuclear atypia, mitotic activity, and invasive growth.
;[487..506]:malignancy:"liver cell adenomas"
(SENT
  (S
    (NP-SBJ-2
      (NP (JJ:[457..469] Differential) (NN:[470..479] diagnosis))
      (PP (IN:[480..482] of)
        (NP (DT:[483..486] the)
          
          (NML (NN:[487..492] liver) (NN:[493..497] cell))
          (NNS:[498..506] adenomas)))
      (PP (IN:[507..509] on)
        (NP
          (NP (DT:[510..513] the) (NN:[514..519] basis))
          (PP (IN:[520..522] of)
            (NP (JJ:[524..539] histopathologic) (NNS:[540..548] findings))))))
    (VP
      (VP (VBD:[549..555] proved)
        (S
          (NP-SBJ (-NONE-:[555..555] *))
          (ADJP-PRD (JJ:[556..565] difficult))))
      (CC:[566..569] and)
      (VP (VBD:[570..573] was)
        (VP (VBN:[574..579] based)
          (NP-2 (-NONE-:[579..579] *))
          (PP-CLR (IN:[580..582] on)
            (NP
              (NP (DT:[583..586] the) (NN:[587..594] absence))
              (PP (IN:[595..597] of)
                (NP
                  (NP
                    (NP (JJ:[599..607] cellular)
                      (NML-1 (-NONE-:[607..607] *P*)))
                    (CC:[608..611] and)
                    (NP (JJ:[612..619] nuclear)
                      (NML-1 (NN:[620..626] atypia))))
                  (,:[626..627] ,)
                  (NP (JJ:[628..635] mitotic) (NN:[636..644] activity))
                  (,:[644..645] ,) (CC:[646..649] and)
                  (NP (JJ:[650..658] invasive) (NN:[659..665] growth)))))))))
    (.:[665..666] .)))

;sentence 7 Span:667..844
;In both  cases, immunohistochemical staining demonstrated the nuclear
;accumulation of  beta-catenin, and in 1 case, the tumor cells carried a
;mutation of the  beta-catenin gene.
;[676..681]:malignancy:"cases"
;[754..766]:gene-protein:"beta-catenin"
;[777..781]:malignancy:"case"
;[787..798]:malignancy:"tumor cells"
;[826..838]:gene-rna:"beta-catenin"
(SENT
  (S
    (S
      (PP (IN:[667..669] In)
        (NP (DT:[670..674] both) (NNS:[676..681] cases)))
      (,:[681..682] ,)
      (NP-SBJ (JJ:[683..702] immunohistochemical) (NN:[703..711] staining))
      (VP (VBD:[712..724] demonstrated)
        (NP
          (NP (DT:[725..728] the) (JJ:[729..736] nuclear)
              (NN:[737..749] accumulation))
          (PP (IN:[750..752] of)
            (NP (NN:[754..766] beta-catenin))))))
    (,:[766..767] ,) (CC:[768..771] and)
    (S
      (PP (IN:[772..774] in)
        (NP (CD:[775..776] 1) (NN:[777..781] case)))
      (,:[781..782] ,)
      (NP-SBJ (DT:[783..786] the)
         (NN:[787..792] tumor) (NNS:[793..798] cells))
      (VP (VBD:[799..806] carried)
        (NP
          (NP (DT:[807..808] a) (NN:[809..817] mutation))
          (PP (IN:[818..820] of)
            (NP (DT:[821..824] the) (NN:[826..838] beta-catenin)
                (NN:[839..843] gene))))))
    (.:[843..844] .)))

;sentence 8 Span:845..1067
;Recently, disregulation of the Wnt/beta-catenin pathway,  attributable to
;abnormalities of the beta-catenin gene, has been reported to be  a major
;event in the development of hepatocellular carcinomas and  hepatoblastomas.
;[876..879]:gene-protein:"Wnt"
;[880..892]:gene-protein:"beta-catenin"
;[940..952]:gene-rna:"beta-catenin"
;[1020..1045]:malignancy:"hepatocellular carcinomas"
;[1051..1066]:malignancy:"hepatoblastomas"
(SENT
  (S
    (ADVP-TMP (RB:[845..853] Recently))
    (,:[853..854] ,)
    (NP-SBJ-1
      (NP
        (NP (NN:[855..868] disregulation))
        (PP (IN:[869..871] of)
          (NP (DT:[872..875] the)
            (NML (NN:[876..879] Wnt) (SYM:[879..880] /)
                 (NN:[880..892] beta-catenin))
            (NN:[893..900] pathway))))
      (,:[900..901] ,)
      (ADJP (JJ:[903..915] attributable)
        (PP (TO:[916..918] to)
          (NP
            (NP (NNS:[919..932] abnormalities))
            (PP (IN:[933..935] of)
              (NP (DT:[936..939] the) (NN:[940..952] beta-catenin)
                  (NN:[953..957] gene)))))))
    (,:[957..958] ,)
    (VP (VBZ:[959..962] has)
      (VP (VBN:[963..967] been)
        (VP (VBN:[968..976] reported)
          (S
            (NP-SBJ-1 (-NONE-:[976..976] *))
            (VP (TO:[977..979] to)
              (VP (VB:[980..982] be)
                (NP-PRD (DT:[984..985] a) (JJ:[986..991] major)
                        (NN:[992..997] event))
                (PP (IN:[998..1000] in)
                  (NP
                    (NP (DT:[1001..1004] the) (NN:[1005..1016] development))
                    (PP (IN:[1017..1019] of)
                      (NP
                        (NP (JJ:[1020..1034] hepatocellular)
                            (NNS:[1035..1045] carcinomas))
                        (CC:[1046..1049] and)
                        (NP (NNS:[1051..1066] hepatoblastomas))))))))))))
    (.:[1066..1067] .)))

;sentence 9 Span:1068..1172
;Our report may be the first to describe the beta-catenin  abnormalities in
;childhood liver cell adenoma.
;[1112..1124]:gene-rna:"beta-catenin"
;[1143..1171]:malignancy:"childhood liver cell adenoma"
(SENT
  (S
    (NP-SBJ (PRP$:[1068..1071] Our) (NN:[1072..1078] report))
    (VP (MD:[1079..1082] may)
      (VP (VB:[1083..1085] be)
        (NP-PRD
          (NP (DT:[1086..1089] the) (JJ:[1090..1095] first))
          (SBAR
            (WHNP (-NONE-:[1095..1095] 0))
            (S
              (NP-SBJ (-NONE-:[1095..1095] *))
              (VP (TO:[1096..1098] to)
                (VP (VB:[1099..1107] describe)
                  (NP (DT:[1108..1111] the) (NN:[1112..1124] beta-catenin)
                      (NNS:[1126..1139] abnormalities))
                  (PP (IN:[1140..1142] in)
                    (NP (NN:[1143..1152] childhood)
                      (NML (NN:[1153..1158] liver) (NN:[1159..1163] cell))
                      (NN:[1164..1171] adenoma))))))))))
    (.:[1171..1172] .)))

;sentence 10 Span:1173..1293
;These findings imply that  abnormalities of beta-catenin can be an early
;initiating event in human liver  tumorigenesis.
;[1217..1229]:gene-rna:"beta-catenin"
(SENT
  (S
    (NP-SBJ (DT:[1173..1178] These) (NNS:[1179..1187] findings))
    (VP (VBP:[1188..1193] imply)
      (SBAR (IN:[1194..1198] that)
        (S
          (NP-SBJ
            (NP (NNS:[1200..1213] abnormalities))
            (PP (IN:[1214..1216] of)
              (NP (NN:[1217..1229] beta-catenin))))
          (VP (MD:[1230..1233] can)
            (VP (VB:[1234..1236] be)
              (NP-PRD (DT:[1237..1239] an) (JJ:[1240..1245] early)
                      (VBG:[1246..1256] initiating) (NN:[1257..1262] event))
              (PP (IN:[1263..1265] in)
                (NP (JJ:[1266..1271] human) (NN:[1272..1277] liver)
                    (NN:[1279..1292] tumorigenesis))))))))
    (.:[1292..1293] .)))

;sentence 11 Span:1294..1333
;Copyright 2002, Elsevier Science (USA).
(SENT
  (FRAG (NN:[1294..1303] Copyright) (CD:[1304..1308] 2002) (,:[1308..1309] ,)
        (NNP:[1310..1318] Elsevier) (NNP:[1319..1326] Science)
        (-LRB-:[1327..1328] -LRB-) (NNP:[1328..1331] USA)
        (-RRB-:[1331..1332] -RRB-) (.:[1332..1333] .)))

;section 12 Span:1334..1354
;All rights reserved.
(SEC
  (FRAG (DT:[1334..1337] All) (NNS:[1338..1344] rights)
        (VBN:[1345..1353] reserved) (.:[1353..1354] .)))

;section 13 Span:1358..1403
;PMID: 12203220 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1358..1362] PMID) (::[1362..1363] :) (CD:[1364..1372] 12203220)
        (NN:[1373..1374] -LSB-) (NNP:[1374..1380] PubMed) (::[1381..1382] -)
        (NN:[1383..1390] indexed) (IN:[1391..1394] for)
        (NNP:[1395..1403] MEDLINE-RSB-)))
